JP2018040799A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2018040799A5 JP2018040799A5 JP2017171651A JP2017171651A JP2018040799A5 JP 2018040799 A5 JP2018040799 A5 JP 2018040799A5 JP 2017171651 A JP2017171651 A JP 2017171651A JP 2017171651 A JP2017171651 A JP 2017171651A JP 2018040799 A5 JP2018040799 A5 JP 2018040799A5
- Authority
- JP
- Japan
- Prior art keywords
- assay result
- sample
- assay
- lipid
- measurement
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 238000003556 assay Methods 0.000 description 12
- 150000002632 lipids Chemical class 0.000 description 4
- 238000005259 measurement Methods 0.000 description 4
- 101800004937 Protein C Proteins 0.000 description 2
- 102100036546 Salivary acidic proline-rich phosphoprotein 1/2 Human genes 0.000 description 2
- 101800001700 Saposin-D Proteins 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 238000005119 centrifugation Methods 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 229960000856 protein c Drugs 0.000 description 2
- 230000015271 coagulation Effects 0.000 description 1
- 238000005345 coagulation Methods 0.000 description 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP16187839.2A EP3293521B1 (de) | 2016-09-08 | 2016-09-08 | Herstellung lipämischer plasma- oder serumproben für die bestimmung einer lipidinterferenz |
| EP16187839.2 | 2016-09-08 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2018040799A JP2018040799A (ja) | 2018-03-15 |
| JP2018040799A5 true JP2018040799A5 (enExample) | 2020-09-03 |
| JP7022538B2 JP7022538B2 (ja) | 2022-02-18 |
Family
ID=56936286
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2017171651A Active JP7022538B2 (ja) | 2016-09-08 | 2017-09-07 | 脂質妨害の決定のための脂肪血症血漿または血清試料の調製 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US10488308B2 (enExample) |
| EP (1) | EP3293521B1 (enExample) |
| JP (1) | JP7022538B2 (enExample) |
| CN (1) | CN107807024B (enExample) |
| CA (1) | CA2978476C (enExample) |
| ES (1) | ES2720779T3 (enExample) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP7097514B2 (ja) * | 2019-01-29 | 2022-07-07 | シーメンス・ヘルスケア・ダイアグノスティックス・インコーポレイテッド | ヘモグロビンＡ１ｃアッセイにおける濁度正規化アルゴリズム及びイントラリピッド／脂肪血症干渉を低減する方法 |
| CN111929449A (zh) * | 2020-08-28 | 2020-11-13 | 保定天岳生物工程有限公司 | 一种aptt检测试剂盒 |
| CN116422481A (zh) * | 2022-01-11 | 2023-07-14 | 汾沃有限公司 | 基于脂质浓度对离心机中的目标界面位置进行调整 |
| CN119901692B (zh) * | 2023-10-28 | 2025-12-02 | 柏荣诊断产品（上海）有限公司 | 一种减弱脂血对透散射融合增强免疫比浊检测影响的方法 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS4977685A (enExample) * | 1972-11-29 | 1974-07-26 | ||
| DE4223355A1 (de) * | 1992-07-16 | 1994-01-20 | Boehringer Mannheim Gmbh | Verfahren und Reagenz zur spezifischen Bestimmung von LDL in Serumproben |
| JP4273311B2 (ja) * | 2002-04-26 | 2009-06-03 | 株式会社シノテスト | 試料中の測定対象物質の測定方法及び測定試薬 |
| CN101398422B (zh) * | 2008-10-28 | 2012-09-05 | 四川大学华西医院 | 高甘油三脂对血红蛋白浓度测定干扰的消除方法 |
| US20130084592A1 (en) * | 2011-10-04 | 2013-04-04 | Siemens Healthcare Diagnostics Inc. | Methods for correcting assay measurements |
-
2016
- 2016-09-08 EP EP16187839.2A patent/EP3293521B1/de active Active
- 2016-09-08 ES ES16187839T patent/ES2720779T3/es active Active
-
2017
- 2017-09-05 CN CN201710789597.6A patent/CN107807024B/zh active Active
- 2017-09-06 CA CA2978476A patent/CA2978476C/en active Active
- 2017-09-07 US US15/698,618 patent/US10488308B2/en active Active
- 2017-09-07 JP JP2017171651A patent/JP7022538B2/ja active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2018040799A5 (enExample) | ||
| CL2019003114A1 (es) | Anticuerpos anti–tau y métodos de uso (divisional solicitud 201703063) | |
| MA43982A (fr) | Anticorps anti-tnf, compositions, méthodes et utilisation pour le traitement ou la prévention du diabète de type 1 | |
| BR112018070260A2 (pt) | receptores quiméricos e métodos de uso dos mesmos | |
| WO2017120523A3 (en) | Anti-pro/latent myostatin antibodies and methods of use thereof | |
| BR112013023540A2 (pt) | anticorpo, kit e método para a determinação de peptídeos amilóides | |
| WO2012177940A3 (en) | Microfluidic devices and methods for separating and detecting constituents in a fluid sample | |
| DK3524600T3 (da) | Fremgangsmåder og mellemprodukter til fremstilling af hidtil ukendte substituerede 6,7-dihydro-5h-benzo[7]annulenforbindelser | |
| WO2014015194A3 (en) | Methods for detecting and measuring aggregation | |
| WO2014134561A3 (en) | Quantification of vaccine compositions | |
| CA3204788C (en) | Antibodies comprising an antigen-binding site that specifically binds to two different epitopes and methods of making them | |
| JP2014132019A5 (enExample) | ||
| SG10201902850TA (en) | Human-derived anti-dipeptide repeats (dprs) antibody | |
| EA201792289A1 (ru) | Способы обнаружения агглютинации и композиции для их осуществления | |
| ZA202002415B (en) | Detection of symmetrical dimethylarginine | |
| WO2015006337A3 (en) | Compositions and methods for increasing protein half-life in a serum | |
| MX2016001573A (es) | Ensayos para timp2 con mejor rendimiento en muestras biológicas. | |
| WO2015112558A3 (en) | Peptides, devices, and methods for the detection of anaplasma antibodies | |
| CN110198739A (zh) | 一种pd-l1抗体药物组合物及其用途 | |
| WO2017194903A3 (fr) | Particule virale pour le transfert d'arns, notamment dans les cellules impliquées dans la réponse immune | |
| JP2018528441A5 (enExample) | ||
| EA201991506A1 (ru) | Системы и способы для тестирования и скрининга с использованием связанных с соединениями субстратов | |
| JP2016501516A5 (enExample) | ||
| WO2015023503A3 (en) | Compositions and methods for multimodal analysis of cmet nucleic acids | |
| WO2015143194A3 (en) | Immunogenetic restriction on elicitation of antibodies |